Small-Molecule Transcription Factor Inhibitors in Oncology
Rahman, Khondaker Miraz / Thurston, David E
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be "reprogrammed", leading to apoptosis or differentiation from the malignant phenotype. As the use of kinase inhibitors is gradually declining, transcription factor inhibition is the next hot topic for oncology research and merits much attention.
Small-Molecule Transcription Factor I...